产品中心Products Resources
联系我们CONTACT US
-
400 179 0116
24小时服务热线
产品描述/Products Description
背景介绍/context:
Human iPSC-Derived Neural Stem Cells that have been genetically edited using CRISPR-Cas9 technology to introduce the R406W mutation (CGG>TGG) into the MAPT gene. This line is homozygous for the R406W mutation so both alleles contain the mutation.
The R406W mutation in MAPT has been implicated in familial frontotemporal dementia and parkinsonism (Hutton et al., 1998; Behnam et al., 2015) and has been seen in patients with clinical presentation resembling Alzheimer's disease (Rademakers et al., 2003; Lindquist et al., 2008). The R406W mutation reduces the ability of MAPT/tau to bind to microtubules in vitro (Hong et al., 1998).
动物种别/Organism 人
组织来源 Tissue and Cell Type 神经干细胞
形态/Morphology 贴壁生长
注意事项:此产品仅供科研使用